The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
On the medicinal chemistry of gold complexes as anticancer drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
New trends for metal complexes with anticancer activity
Bruijnincx, P. C., & Sadler, P. J. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.11.013 · Cited by 1,306
Shaw, C. F. (1999) · Chemical Reviews · doi:10.1021/cr980431o · Cited by 990
Galanski, M. S., Jakupec, M. A., & Keppler, B. K. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867054637626 · Cited by 721
Non Platinum Metal Complexes as Anti‐cancer Drugs
Ott, I., & Gust, R. (2007) · Archiv der Pharmazie · doi:10.1002/ardp.200600151 · Cited by 609
Self-citationUsing coordination chemistry to design new medicines
Ronconi, L., & Sadler, P. J. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2006.11.017 · Cited by 608
Hickey, J. L., Ruhayel, R. A., Barnard, P. J., Baker, M. V., Berners-Price, S. J., & Filipovska, A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja804027j · Cited by 599
The thioredoxin system in cancer
Arnér, E. S. J., & Holmgren, A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.10.009 · Cited by 589
Human Placenta Thioredoxin Reductase
Gromer, S., Arscott, L. D., Williams, C. H., Schirmer, R. H., & Becker, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20096 · Cited by 536
The thioredoxin system—From science to clinic
Gromer, S., Urig, S., & Becker, K. (2004) · Medicinal Research Reviews · doi:10.1002/med.10051 · Cited by 479
Targeting the mitochondrial cell death pathway with gold compounds
Barnard, P. J., & Berners-Price, S. J. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2007.04.006 · Cited by 417
Marzano, C., Gandin, V., Folda, A., Scutari, G., Bindoli, A., & Rigobello, M. P. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.12.021 · Cited by 415
Thioredoxin reductase as a pathophysiological factor and drug target
Becker, K., Gromer, S., Schirmer, R. H., & Müller, S. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01703.x · Cited by 388
Thioredoxin reductase: Two modes of catalysis have evolved
Williams, C. H., Arscott, L. D., Müller, S., Lennon, B. W., Ludwig, M. L., Wang, P., Veine, D. M., Becker, K., & Schirmer, R. H. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01702.x · Cited by 343
On the potential of thioredoxin reductase inhibitors for cancer therapy
Urig, S., & Becker, K. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.09.004 · Cited by 337
Milacic, V., Chen, D., Ronconi, L., Landis-Piwowar, K. R., Fregona, D., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3017 · Cited by 317
Ronconi, L., Marzano, C., Zanello, P., Corsini, M., Miolo, G., Maccà, C., Trevisan, A., & Fregona, D. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0509288 · Cited by 314
Mirabelli, C. K., Johnson, R. K., Sung, C. M., Faucette, L. F., Muirhead, K. A., & Crooke, S. T. (1985) · PubMed · Cited by 295
Naphthalimides as Anticancer Agents: Synthesis and Biological Activity
Brana, M., & Ramos, A. (2001) · Current Medicinal Chemistry-Anti-Cancer Agents · doi:10.2174/1568011013354624 · Cited by 281
Exploring biologically relevant chemical space with metal complexes
Meggers, E. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.05.013 · Cited by 274
Marcon, G., Carotti, S., Coronnello, M., Messori, L., Mini, E., Orioli, P., Mazzei, T., Cinellu, M. A., & Minghetti, G. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010997w · Cited by 266
Thioredoxin signaling as a target for cancer therapy
Powis, G., & Kirkpatrick, D. L. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.04.003 · Cited by 264
Ghezzi, A., Aceto, M., Cassino, C., Gabano, E., & Osella, D. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2003.08.014 · Cited by 248
Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions
Pia Rigobello, M., Messori, L., Marcon, G., Agostina Cinellu, M., Bragadin, M., Folda, A., Scutari, G., & Bindoli, A. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.04.020 · Cited by 213
Undressing of Phosphine Gold( I ) Complexes as Irreversible Inhibitors of Human Disulfide Reductases
Urig, S., Fritz‐Wolf, K., Réau, R., Herold‐Mende, C., Tóth, K., Davioud‐Charvet, E., & Becker, K. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502756 · Cited by 206
Casini, A., Cinellu, M. A., Minghetti, G., Gabbiani, C., Coronnello, M., Mini, E., & Messori, L. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060436a · Cited by 194
Wang, Y., He, Q.-Y., Sun, R. W.-Y., Che, C.-M., & Chiu, J.-F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2867 · Cited by 190
Rackham, O., Nichols, S. J., Leedman, P. J., Berners-Price, S. J., & Filipovska, A. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.022 · Cited by 186
Induction of mitochondrial permeability transition by auranofin, a Gold(I)‐phosphine derivative
Rigobello, M. P., Scutari, G., Boscolo, R., & Bindoli, A. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704823 · Cited by 178
Giovagnini, L., Ronconi, L., Aldinucci, D., Lorenzon, D., Sitran, S., & Fregona, D. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049191x · Cited by 175
Sannella, A. R., Casini, A., Gabbiani, C., Messori, L., Bilia, A. R., Vincieri, F. F., Majori, G., & Severini, C. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.02.028 · Cited by 172
Mirabelli, C. K., Hill, D. T., Faucette, L. F., McCabe, F. L., Girard, G. R., Bryan, D. B., Sutton, B. M., Barus, J. O. L., Crooke, S. T., & Johnson, R. K. (1987) · Journal of Medicinal Chemistry · doi:10.1021/jm00395a004 · Cited by 172
Towards the rational design of platinum(ii) and gold(iii) complexes as antitumour agents
Wang, X., & Guo, Z. (2008) · Dalton Trans. · doi:10.1039/b715903j · Cited by 160
Saggioro, D., Rigobello, M. P., Paloschi, L., Folda, A., Moggach, S. A., Parsons, S., Ronconi, L., Fregona, D., & Bindoli, A. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.08.016 · Cited by 151
Gold(I)-Mediated Inhibition of Protein Tyrosine Phosphatases: A Detailed in Vitro and Cellular Study
Krishnamurthy, D., Karver, M. R., Fiorillo, E., Orrù, V., Stanford, S. M., Bottini, N., & Barrios, A. M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800101w · Cited by 127
Chrysotherapy: a synoptic review
Eisler, R. (2003) · Inflammation Research · doi:10.1007/s00011-003-1208-2 · Cited by 123
Interaction of Gold(I) with the Active Site of Selenium-Glutathione Peroxidase
Chaudière, J., & Tappel, A. L. (1984) · Journal of Inorganic Biochemistry · doi:10.1016/0162-0134(84)85030-8 · Cited by 119
Aurothiomalate Inhibits Transformed Growth by Targeting the PB1 Domain of Protein Kinase Cι
Erdogan, E., Lamark, T., Stallings‐Mann, M. L., Jamieson, L., Pellechia, M., Thompson, E. A., Johansen, T., & Fields, A. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606054200 · Cited by 103
Deponte, M., Urig, S., Arscott, L. D., Fritz‐Wolf, K., Réau, R., Herold‐Mende, C. C., Končarević, S., Meyer, M., Davioud–Charvet, E., Ballou, D. P., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412519200 · Cited by 93
Wang, Y., He, Q., Che, C., & Chiu, J. (2005) · PROTEOMICS · doi:10.1002/pmic.200402027 · Cited by 87
Jellicoe, M. M., Nichols, S. J., Callus, B. A., Baker, M. V., Barnard, P. J., Berners‐Price, S. J., Whelan, J., Yeoh, G. C., & Filipovska, A. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn093 · Cited by 86
Gold(III) compound is a novel chemocytotoxic agent for hepatocellular carcinoma
Lum, C. T., Yang, Z. F., Li, G. H., Sun, R. W., Fan, S. T., Poon, R. T. P., Lin, M. C. M., Che, C., & Kung, H. F. (2005) · International Journal of Cancer · doi:10.1002/ijc.21484 · Cited by 81
Cellular pharmacological properties of gold(III) porphyrin 1a, a potential anticancer drug lead
Wang, Y., He, Q., Sun, R. W., et al. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.10.034 · Cited by 76
Thioredoxin and Thioredoxin Reductase As Redox-Sensitive Molecular Targets for Cancer Therapy
Pennington, J., JACOBS, K. L. M., Sun, L., Bar‐Sela, G., Mishra, M. V., & Gius, D. R. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207782360537 · Cited by 69
Talbot, S. R., Nelson, R., & Self, W. T. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.161 · Cited by 68
Caruso, F., Rossi, M., Tanski, J. M., Pettinari, C., & Marchetti, F. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0204690 · Cited by 66
Gold(I) complexes determine apoptosis with limited oxidative stress in Jurkat T cells
Rigobello, M. P., Folda, A., Dani, B., Menabò, R., Scutari, G., & Bindoli, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.12.026 · Cited by 65
Interactions of gold coordination complexes with DNA
Mirabelli, C. K., Sung, C.-M., Zimmerman, J. P., Hill, D. T., Mong, S., & Crooke, S. T. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90106-1 · Cited by 61
Thioredoxin reductase and cancer cell growth inhibition by organogold(III) compounds
Engman, L., McNaughton, M., Gajewska, M., Kumar, S., Birmingham, A., & Powis, G. (2006) · Anti-Cancer Drugs · doi:10.1097/00001813-200606000-00007 · Cited by 54
Ott, I., Koch, T., Shorafa, H., Bai, Z., Poeckel, D., Steinhilber, D., & Gust, R. (2005) · Organic & Biomolecular Chemistry · doi:10.1039/b504294c · Cited by 52
Self-citationSuresh, D., Balakrishna, M. S., Rathinasamy, K., Panda, D., & Mobin, S. M. (2008) · Dalton Transactions · doi:10.1039/b804026p · Cited by 51
Smith, P. F., Hoke, G. D., Alberts, D. W., Bugelski, P. J., Lupo, S., Mirabelli, C. K., & Rush, G. F. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23520-0 · Cited by 51
Wang, Y., He, Q., Che, C., Tsao, S. W., Sun, R. W., & Chiu, J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.11.024 · Cited by 47
Caruso, F., Villa, R., Rossi, M., Pettinari, C., Paduano, F., Pennati, M., Daidone, M. G., & Zaffaroni, N. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.11.018 · Cited by 46
Inhibition of Erythrocyte Selenium-Glutathione Peroxidase by Auranofin Analogues and Metabolites
Roberts, J. R., & Shaw, C. F. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00634-5 · Cited by 37
Yamada, M., Niki, H., Yamashita, M., Mue, S., & Ohuchi, K. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36685-6 · Cited by 37
Yamada, R., Sano, H., Hla, T., Hashiramoto, A., Fukui, W., Miyazaki, S., Kohno, M., Tsubouchi, Y., Kusaka, Y., & Kondo, M. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00707-4 · Cited by 29
Yamashita, M., Ichinowatari, G., Yamaki, K., et al. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00053-9 · Cited by 22
The mechanism of acute cytotoxicity of triethylphosphine gold(I) complexes
Hoke, G. D., Rush, G. F., & Mirabelli, C. K. (1989) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(89)90110-5 · Cited by 20
Mirabelli, C. K., Zimmerman, J. P., Bartus, H. R., Chiu-Mei, S., & Crooke, S. T. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90107-3 · Cited by 19
Cited by
Light-Emitting Self-Assembled Materials Based on d8 and d10 Transition Metal Complexes
Yam, V. W.-W., Au, V. K.-M., & Leung, S. Y.-L. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00074 · Cited by 1,661
Organometallic Anticancer Compounds
Gasser, G., Ott, I., & Metzler-Nolte, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100020w · Cited by 1,624
Self-citationMetallodrugs in Medicinal Inorganic Chemistry
Mjos, K. D., & Orvig, C. (2014) · Chemical Reviews · doi:10.1021/cr400460s · Cited by 1,289
Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs
Liu, W., & Gust, R. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35314h · Cited by 762
Chemical biology of anticancer gold(iii) and gold(i) complexes
Zou, T., Lum, C. T., Lok, C.-N., Zhang, J.-J., & Che, C.-M. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00132c · Cited by 628
Metadata
- Authors
- Ott, I.
- Venue
- Coordination Chemistry Reviews
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 253
- Issue
- 11-12
- Pages
- 1670-1681
- ISSN
- 0010-8545 (ISSN-L)
- OpenAlex
- W2017688478
- Cited by
- 825
- References
- 61
- FWCI
- 17.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.